Recent Agents for Treatment of IgAN

Chee Kay Cheung, MBCHB, MRCP, PhD, reviews newly approved agents for the treatment of IgAN, focusing on SGLT2 inhibitors, budesonide, and sparsentan.

Related Keywords

Chee Kay Cheung , ,Newer Agents ,Wigan ,Nephropathy ,Sglt2 Inhibitors ,Sparsentan ,Mechanism Of Action ,